Trinity Biotech logo

Trinity Biotech

TRIB | NASDAQ
Chart Builder DCF Calculator
$7.35
+$0.12 (+1.66%)
At close: Sep 21, 2026, 4:00 PM ET
$7
-$0.35 (-4.76%)
After-hours: Sep 21, 2026, 7:30 PM ET

Market Data

Market Cap
$146.41M
Enterprise Value
$281.69M
Beta
0.97
Average Volume
41.28K
Shares Outstanding (Diluted)
620.92K
Shares Change YoY
31.43%
Institutional Ownership
5.76%
Exchange
NASDAQ
ISIN
US8964386036

Price Performance

Price Change 1M
-29.9%
Price Change 3M
-31.1%
Price Change 6M
-59.6%
Price Change YTD
-67.2%
Price Change 1Y
-79.6%
Price Change 3Y
-93.0%
Price Change 5Y
-97.8%
1M CAGR (ann.)
-37.9%
1Y CAGR (ann.)
-79.6%
5Y CAGR (ann.)
-55.2%
All-Time CAGR
-23.0%

Valuation

PE Ratio
-0.12
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.00
PS Ratio
3.39
Forward PS
N/A
PB Ratio
-2.07
P/FCF Ratio
-23.46
P/Adj. FCF Ratio
-23.46
P/OCF Ratio
-0.73
EV/Sales
6.42
EV/EBIT
-25.03
EV/EBITDA
-32.89
EV/FCF
-44.40
Earnings Yield
-824.5%
FCF Yield
-4.3%
Adj. FCF Yield
-4.3%

Financial Health

Net Debt
$122.01M
Total Debt
$137.98M
Cash & Short-Term Investments
$5.14M
Total Assets
$105.17M
Current Ratio
0.25
Quick Ratio
0.12
Debt / Equity Ratio
-1.92
Debt / EBITDA
-16.11
Debt / FCF
-21.75
OCF / Debt
-0.05
Interest Coverage
-0.53
Altman Z-Score
-2.19
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
35.4%
Operating Profit Margin
-25.7%
EBITDA Margin
-19.5%
Net Profit Margin
-85.3%
FCF Margin
-14.5%
Adj. FCF Margin
-14.5%
SBC / Revenue
0.0%
SBC Impact (per share)
N/A

Returns

Return on Assets
-35.6%
Return on Equity
68.1%
Return on Invested Capital
-15.1%
Return on Capital Employed
31.2%
Return on Tangible Assets
-77.7%

Historical Growth (CAGR)

Revenue CAGR 3Y
-16.3%
Revenue CAGR 5Y
-15.5%
Revenue CAGR 10Y
-7.9%
EPS CAGR 3Y
22.4%
EPS CAGR 5Y
-4.8%
EPS CAGR 10Y
22.1%
FCF CAGR 3Y
36.0%
FCF CAGR 5Y
-19.7%
FCF CAGR 10Y
-8.9%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Dec 9, 2026
EPS Estimate (next Q)
-$8.40
EPS Growth Est (next Q)
2.2%
Revenue Est (next Q)
$9.95M
Revenue Growth Est (next Q)
-30.1%

Cash Flow

Operating Cash Flow
$-6.26M
Free Cash Flow
$-6.34M
Adj. Free Cash Flow
$-6.34M
FCF Per Share
-$10.22
OCF Per Share
-$10.08
OCF/S Ratio
-14.3%

Income Statement

Revenue
$43.86M
Gross Profit
$15.53M
Operating Income
$-11.26M
EBITDA
$-8.57M
Net Income
$-37.43M
EPS (Diluted)
-$60.60
Revenue / Employee
$152.83K
Profit / Employee
$-130.4K
Employees
287

© 2026 bestshares.com. All rights reserved.